Why the study?
Activated clotting time is critical for assessing anticoagulation during interventional cardiology and cardiac surgery, requiring review of its physiological basis, monitoring techniques, and individualized targets.
Monitoring activated clotting time with a target of 300-400 seconds is recommended to balance bleeding and thrombotic risks during interventional cardiology and cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Guides heparin dosing to balance procedural risks; reinforces literature consensus on ACT targets.
Łubiarz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: